- Injective integrates with the Kava Network to enhance access to stable assets such as USDt.
- INJ surged over 94.5% in the past month, hitting a 17-month high at $15.72.
Injective (INJ) has displayed a significant surge of over 517% in the past year, reaching a 17-month high of $15.72. This price rally comes in the wake of a strategic collaboration with the Kava Network, aiming to expand access to stable assets like USDt.
Injective has officially integrated @KAVA_CHAIN to expand access into stable asset interoperability for tokens such as USDt.
— Injective 🥷 (@Injective_) November 2, 2023
Kava recently announced a partnership with the Tether Foundation, solidifying its plans to natively issue USDt tokens within the broader Cosmos ecosystem. This development has set the stage for an exciting collaboration between Kava and Injective.
One of the key features of this collaboration is the direct Inter-Blockchain Communication (IBC) bridging of USDt from Kava into Injective. This integration promises to enhance liquidity and accessibility within the Injective ecosystem. Additionally, the Kava community has shown its support by approving a governance proposal designed to incentivize the usage of USDt on Injective, rewarding participants with Kava tokens.
Injective, an open and interoperable layer-one blockchain, empowers DeFi with innovative applications, including decentralized exchange infrastructure and oracles. Kava Network, a fast and secure Layer-1 blockchain, combines Cosmos SDK speed with Ethereum Virtual Machine versatility.
Injective (INJ) on the Rise
At the time of writing, the price of Injective (INJ) stands at $15.17, reflecting an 8% increase in the last 24 hours and a 29% surge over the past week. With the integration of Kava and the backing of the Tether Foundation, Injective appears to be well-positioned for continued growth and innovation in the decentralized finance space. On the other hand, the Kava (KAVA) price also soared over 6% in the last 24 hours to $0.6994.